Your browser doesn't support javascript.
loading
The BRCA2 mutation status shapes the immune phenotype of prostate cancer.
Jenzer, Maximilian; Keß, Peter; Nientiedt, Cathleen; Endris, Volker; Kippenberger, Maximilian; Leichsenring, Jonas; Stögbauer, Fabian; Haimes, Josh; Mishkin, Skyler; Kudlow, Brian; Kaczorowski, Adam; Zschäbitz, Stefanie; Volckmar, Anna-Lena; Sültmann, Holger; Jäger, Dirk; Duensing, Anette; Schirmacher, Peter; Hohenfellner, Markus; Grüllich, Carsten; Stenzinger, Albrecht; Duensing, Stefan.
Afiliação
  • Jenzer M; Section of Molecular Urooncology, Department of Urology, University of Heidelberg School of Medicine, Im Neuenheimer Feld 517, 69120, Heidelberg, Germany.
  • Keß P; Department of Medical Oncology, University of Heidelberg School of Medicine, National Center for Tumor Diseases (NCT), Im Neuenheimer Feld 460, 69120, Heidelberg, Germany.
  • Nientiedt C; Section of Molecular Urooncology, Department of Urology, University of Heidelberg School of Medicine, Im Neuenheimer Feld 517, 69120, Heidelberg, Germany.
  • Endris V; Section of Molecular Urooncology, Department of Urology, University of Heidelberg School of Medicine, Im Neuenheimer Feld 517, 69120, Heidelberg, Germany.
  • Kippenberger M; Department of Medical Oncology, University of Heidelberg School of Medicine, National Center for Tumor Diseases (NCT), Im Neuenheimer Feld 460, 69120, Heidelberg, Germany.
  • Leichsenring J; Institute of Pathology, University of Heidelberg School of Medicine, Im Neuenheimer Feld 224, 69120, Heidelberg, Germany.
  • Stögbauer F; Section of Molecular Urooncology, Department of Urology, University of Heidelberg School of Medicine, Im Neuenheimer Feld 517, 69120, Heidelberg, Germany.
  • Haimes J; Institute of Pathology, University of Heidelberg School of Medicine, Im Neuenheimer Feld 224, 69120, Heidelberg, Germany.
  • Mishkin S; Institute of Pathology, University of Heidelberg School of Medicine, Im Neuenheimer Feld 224, 69120, Heidelberg, Germany.
  • Kudlow B; ArcherDX, 2477 55th Street, Boulder, CO, 80301, USA.
  • Kaczorowski A; ArcherDX, 2477 55th Street, Boulder, CO, 80301, USA.
  • Zschäbitz S; ArcherDX, 2477 55th Street, Boulder, CO, 80301, USA.
  • Volckmar AL; Section of Molecular Urooncology, Department of Urology, University of Heidelberg School of Medicine, Im Neuenheimer Feld 517, 69120, Heidelberg, Germany.
  • Sültmann H; Section of Molecular Urooncology, Department of Urology, University of Heidelberg School of Medicine, Im Neuenheimer Feld 517, 69120, Heidelberg, Germany.
  • Jäger D; Department of Medical Oncology, University of Heidelberg School of Medicine, National Center for Tumor Diseases (NCT), Im Neuenheimer Feld 460, 69120, Heidelberg, Germany.
  • Duensing A; Institute of Pathology, University of Heidelberg School of Medicine, Im Neuenheimer Feld 224, 69120, Heidelberg, Germany.
  • Schirmacher P; National Center for Tumor Diseases, German Cancer Research Center, Cancer Genome Research, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany.
  • Hohenfellner M; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Grüllich C; Department of Medical Oncology, University of Heidelberg School of Medicine, National Center for Tumor Diseases (NCT), Im Neuenheimer Feld 460, 69120, Heidelberg, Germany.
  • Stenzinger A; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, USA.
  • Duensing S; Department of Pathology, University of Pittsburgh School of Medicine, 5117 Centre Avenue, Pittsburgh, PA, 15213, USA.
Cancer Immunol Immunother ; 68(10): 1621-1633, 2019 Oct.
Article em En | MEDLINE | ID: mdl-31549213

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Genes BRCA2 / Mutação Limite: Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Genes BRCA2 / Mutação Limite: Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article